Eledon Pharmaceuticals, Inc. (ELDN) Social Stream
Eledon Pharmaceuticals Inc (ELDN) Price Targets From Analysts
Use the tables below to see what analysts covering Eledon Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ELDN reports an average of 238.92% for its upside potential over the past 32 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ELDN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Eledon Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 95.58% of all US stocks.
- Eledon Pharmaceuticals Inc's number of analysts covering the stock is higher than 79.36% of stocks in the small market cap category.
- Eledon Pharmaceuticals Inc's variance in analysts' estimates is lower than 25.4% of stocks in the small market cap category.
- The average analyst price target of ELDN is higher than 71.76% of stocks in the small market cap category.
Make investment decisions regarding ELDN using the data that counts. Try POWR Ratings for free.